Stephanie Collins Reed1, Suzette M Evans2. 1. Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, Columbia University Medical Center, 1051 Riverside Drive, Unit 66, New York, NY 10032 USA. Electronic address: sc2432@cumc.columbia.edu. 2. Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, Columbia University Medical Center, 1051 Riverside Drive, Unit 66, New York, NY 10032 USA.
Abstract
BACKGROUND: Effective treatments for cocaine use disorders remain elusive. Two factors that may be related to treatment failures are route of cocaine used and impulsivity. Smoked cocaine users are more likely to have poorer treatment outcomes compared to intranasal cocaine users. Further, cocaine users are impulsive and impulsivity is associated with poor treatment outcomes. While stimulants are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and attenuate certain cocaine-related behaviors, few studies have comprehensively examined whether stimulants can reduce behavioral impulsivity in cocaine users, and none examined route of cocaine use as a factor. METHODS: The effects of immediate release oral d-amphetamine (AMPH) were examined in 34 cocaine users (13 intranasal, 21 smoked). Participants had three separate sessions where they were administered AMPH (0, 10, or 20mg) and completed behavioral measures of impulsivity and risk-taking and subjective measures of abuse liability. RESULTS: Smoked cocaine users were more impulsive on the Delayed Memory Task, the GoStop task and the Delay Discounting Task than intranasal cocaine users. Smoked cocaine users also reported more cocaine craving and negative mood than intranasal cocaine users. AMPH produced minimal increases on measures of abuse liability (e.g., Drug Liking). CONCLUSIONS: Smoked cocaine users were more impulsive than intranasal cocaine users on measures of impulsivity that had a delay component. Additionally, although AMPH failed to attenuate impulsive responding, there was minimal evidence of abuse liability in cocaine users. These preliminary findings need to be confirmed in larger samples that control for route and duration of cocaine use.
BACKGROUND: Effective treatments for cocaine use disorders remain elusive. Two factors that may be related to treatment failures are route of cocaine used and impulsivity. Smoked cocaine users are more likely to have poorer treatment outcomes compared to intranasal cocaine users. Further, cocaine users are impulsive and impulsivity is associated with poor treatment outcomes. While stimulants are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and attenuate certain cocaine-related behaviors, few studies have comprehensively examined whether stimulants can reduce behavioral impulsivity in cocaine users, and none examined route of cocaine use as a factor. METHODS: The effects of immediate release oral d-amphetamine (AMPH) were examined in 34 cocaine users (13 intranasal, 21 smoked). Participants had three separate sessions where they were administered AMPH (0, 10, or 20mg) and completed behavioral measures of impulsivity and risk-taking and subjective measures of abuse liability. RESULTS: Smoked cocaine users were more impulsive on the Delayed Memory Task, the GoStop task and the Delay Discounting Task than intranasal cocaine users. Smoked cocaine users also reported more cocaine craving and negative mood than intranasal cocaine users. AMPH produced minimal increases on measures of abuse liability (e.g., Drug Liking). CONCLUSIONS: Smoked cocaine users were more impulsive than intranasal cocaine users on measures of impulsivity that had a delay component. Additionally, although AMPH failed to attenuate impulsive responding, there was minimal evidence of abuse liability in cocaine users. These preliminary findings need to be confirmed in larger samples that control for route and duration of cocaine use.
Authors: Matthias Vonmoos; Lea M Hulka; Katrin H Preller; Daniela Jenni; Claudia Schulz; Markus R Baumgartner; Boris B Quednow Journal: Drug Alcohol Depend Date: 2013-06-24 Impact factor: 4.492
Authors: Shijing Liu; Scott D Lane; Joy M Schmitz; Andrew J Waters; Kathryn A Cunningham; F Gerard Moeller Journal: Am J Drug Alcohol Abuse Date: 2011-01-05 Impact factor: 3.829
Authors: Danielle M Dick; Gregory Smith; Peter Olausson; Suzanne H Mitchell; Robert F Leeman; Stephanie S O'Malley; Kenneth Sher Journal: Addict Biol Date: 2010-04 Impact factor: 4.280
Authors: Scott D Lane; Charles E Green; Joy M Schmitz; Nuvan Rathnayaka; Wendy B Fang; Sergi Ferré; F Gerard Moeller Journal: J Addict Res Ther Date: 2014
Authors: Karolina Kozak; Aliya M Lucatch; Darby J E Lowe; Iris M Balodis; James MacKillop; Tony P George Journal: Ann N Y Acad Sci Date: 2018-10-05 Impact factor: 5.691
Authors: Elena Colicino; Danielle B Hazeltine; Kelly M Schneider; Anna Zilverstand; Keren Bachi; Nelly Alia-Klein; Rita Z Goldstein; Andy C Todd; Megan K Horton Journal: Environ Dis Date: 2019-09-27